骨小梁金属垫块治疗无骨盆不连续的Paprosky III型缺损:先前报告4年临床结果病例的平均11年随访
本回顾性病例系列纳入83髋(82例)因Paprosky IIIA/IIIB型缺损无骨盆不连续行翻修全髋关节置换术并使用骨小梁金属(TM)垫块联合非骨水泥TM髋臼杯的患者,53例完成平均11年随访。Harris髋关节评分从术前36.4升至末次随访87.4;7年及10年髋臼假体生存率(任何原因翻修)分别为90.6%和86.3%。作者认为该技术可考虑作为此类缺损的有效处理方式,中期临床与影像学结果良好。
要点
- Paprosky IIIA型42髋、IIIB型11髋,平均随访11年,Harris髋关节评分从36.4升至87.4。
- 7年髋臼假体生存率(任何翻修)90.6%,10年86.3%;无菌性松动翻修7年94.2%,10年92.1%。
- 作者认为TM髋臼杯联合垫块可考虑用于无骨盆不连续的Paprosky III型缺损。
核心结论
- 作者认为,使用TM髋臼杯和垫块可考虑作为无骨盆不连续的Paprosky III型缺损的有效处理方式。
- 作者认为该技术可实现缺损的解剖重建并恢复髋关节旋转中心,中期临床与影像学结果良好。
研究设计与样本
- 回顾性病例系列,纳入2005年至2016年间在三级转诊中心接受翻修全髋关节置换术的83髋(82例)。
- 53例完成临床和影像学随访(占总数的64%),平均随访11年(范围7至16.6年)。
- Paprosky IIIA型缺损42髋,IIIB型缺损11髋。
- 此前已报告55髋使用TM髋臼杯联合TM垫块行髋臼重建、平均随访53.7个月的短期结果;本研究随访上述患者并新增28髋。
- 证据等级为IV级,病例系列。
主要发现
- 平均Harris髋关节评分从术前36.4(范围24至53)升至末次随访87.4(范围63至100)。
- 以任何原因翻修计算,髋臼假体7年累积生存率为90.6%(95%CI:78.8至95.9),10年为86.3%(95%CI:73.4至93.2)。
- 以无菌性松动翻修计算,髋臼假体7年累积生存率为94.2%(95%CI:83.2至98.1),10年为92.1%(95%CI:80.4至97)。
- 随访期间7例患者死亡且未接受进一步翻修,23例失访。
临床怎么用
- 作者认为,TM髋臼杯联合垫块可考虑用于无骨盆不连续的Paprosky III型缺损的翻修全髋关节置换术。
- 作者认为该技术可实现缺损的解剖重建并恢复髋关节旋转中心,中期临床与影像学结果良好。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This retrospective case series aimed to assess the clinical and radiographic outcomes of revision total hip arthroplasty with trabecular metal (TM) augments associated with cementless TM acetabular components for the management of Paprosky type IIIA and IIIB defects without pelvic discontinuity. METHODS: There were 83 hips (82 patients) enrolled. There were 53 patients who completed the clinical and radiological follow-up (64% of the total) who had a mean follow-up of 11 years (range, 7 to 16.6). There were seven patients who died during the follow-up period without undergoing further revision, and 23 were lost to follow-up. A Paprosky type IIIA defect was found in 42 hips, whereas a Paprosky type IIIB defect was present in 11 hips. We previously reported short-term outcomes for 55 hips that underwent acetabular reconstruction using TM cups associated with TM augments with a mean follow-up of 53.7 months. Here, we followed the clinical and radiological outcomes of the aforementioned patients and 28 more hips. We retrospectively collected the clinical and radiological data of all the patients operated on in our tertiary referral center between 2005 and 2016. RESULTS: The average Harris Hip Score increased from 36.4 (range, 24 to 53) preoperatively to 87.4 (range, 63 to 100) at the last follow-up. The cumulative survival of the acetabular construct at 7 years of follow-up was 90.6% (95% confidence interval [CI]: 78.8 to 95.9) considering revision for any reason, and at 10 years of follow-up was 86.3% (95% CI: 73.4 to 93.2). The cumulative survival of the acetabular construct at 7 years of follow-up was 94.2% (95% CI: 83.2 to 98.1) considering revision for aseptic loosening, and at 10 years of follow-up was 92.1% (95% CI: 80.4 to 97). CONCLUSIONS: The use of TM cups and augments could be considered an effective management of Paprosky type III defects without pelvic discontinuity. The present technique provides an anatomical reconstruction of the defect with the restoration of the hip center of rotation associated with good clinical and radiographic outcomes in the midterm. LEVEL OF EVIDENCE: Level IV, case series.
引用
- Loppini M, Guazzoni E, Gambaro FM, et al. Trabecular Metal Augments for the Management of Paprosky Type III Defects Without Pelvic Discontinuity: Average 11-Year Follow-Up in Cases With Previously Reported 4-Year Clinical Results. J Arthroplasty. 2024. PMID: 39579802. doi:10.1016/j.arth.2024.11.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。